Agena Bioscience’s CYP2C19 Genotyping Kit Gains NMPA Approval for Cardiovascular Applications
Shanghai-based Agena Bioscience announced that its human CYP2C19 genotyping test kit, co-developed with Simcere Pharmaceutical...
Shanghai-based Agena Bioscience announced that its human CYP2C19 genotyping test kit, co-developed with Simcere Pharmaceutical...
US-based medical technology major Boston Scientific Corporation (NYSE: BSX) has announced the initiation of the...
China-based Lifetech Scientific Corporation (HKG: 1302) has announced that it has received CE MDR certification...
China-based Lifetech Scientific Corporation (HKG: 1302) has announced that it has received CE MDR certification...
AffaMed Technologies, a joint venture between AffaMed Therapeutics and SIFI S.p.A., has announced the completion...
The first accelerator-based boron neutron capture therapy (AB-BNCT) procedures have been performed in China by...
The National Medical Products Administration (NMPA) has approved STmed Technology’s extracorporeal cardiopulmonary support auxiliary equipment...
Johnson & Johnson MedTech’s next-generation QDOT micro diagnostic/ablation deflectable tip catheter, a disposable pressure monitoring...
China-based MicroPort Scientific Corp’s (HKG: 0853) spin-off MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160) has...
China-based urogenital cancer specialist Jiangsu Yahong Meditech Co., Ltd (Asieris, SHA: 688176) has announced that...
We-Linking, a developer of fully implantable wireless brain-computer interface systems based in Shenzhen, has reportedly...
Beijing Chunlizhengda Medical Instruments Co., Ltd (HKG: 1858, SHA: 688236) is poised to acquire a...
Shanghai-based REMD, a leading manufacturer of irreversible electroporation devices, has reportedly raised over RMB 100...
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced the successful completion of the first...
China-based medical device firm Mindray (SHE: 300760) has announced the market launch of the firm’s...
China-based Vertex has announced receiving medical device approval from the National Medical Products Administration (NMPA)...
Hong Kong-based Agilis Robotics Ltd has successfully completed a second round of live animal testing...
Shares in Chinese firm Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) and its partner Novocure...
The National Medical Products Administration (NMPA) has approved Chinabridge (Shenzhen) Medical Technology Co., Ltd’s extracorporeal...
The National Medical Products Administration (NMPA) approved 172 medical devices for marketing in November 2022....